Catalyst Wire Dossier Catalyst Wire Dossier

Losartan Potassium/Hydrochlorothiazide 100/25 mg tablets

losartan potassium and hydrochlorothiazide · Teva Pharmaceuticals USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Losartan Potassium/Hydrochlorothiazide 100/25 mg tablets, covering 2010-09-14 to 2010-09-14. Get the full timeline:

Most recent: Clinical Trial Update: Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions [Phase 1]

See pricing